Literature DB >> 32354773

Diagnostic and therapeutic challenges for patients with ANCA-associated vasculitides at the time of COVID-19. Response to: 'Rituximab for granulomatosis with polyangiitis in the pandemic of COVID-19: lessons from a case with severe pneumonia' by Guilpain et al.

Sara Monti1, Carlomaurizio Montecucco2.   

Abstract

Entities:  

Keywords:  autoimmunity; rituximab; systemic vasculitis

Year:  2020        PMID： 32354773     DOI： 10.1136/annrheumdis-2020-217555

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  4 in total

Review 1.  A Case of Systemic Lupus Erythematosus Flare Triggered by Severe Coronavirus Disease 2019.

Authors:  Sairam Raghavan; Sriram Gonakoti; Iriagbonse Rotimi Asemota; Benjamin Mba
Journal:  J Clin Rheumatol       Date:  2020-09       Impact factor: 3.517

2.  [Hemoptysis and acute kidney injury in COVID-19].

Authors:  A Junginger; M Brucke; B Reiser; O Stahn; G Braun
Journal:  Med Klin Intensivmed Notfmed       Date:  2020-12-14       Impact factor: 0.840

3.  Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β.

Authors:  Donald C Vinh; Laurent Abel; Paul Bastard; Matthew P Cheng; Antonio Condino-Neto; Peter K Gregersen; Filomeen Haerynck; Maria-Pia Cicalese; David Hagin; Pere Soler-Palacín; Anna M Planas; Aurora Pujol; Luigi D Notarangelo; Qian Zhang; Helen C Su; Jean-Laurent Casanova; Isabelle Meyts
Journal:  J Clin Immunol       Date:  2021-06-08       Impact factor: 8.542

Review 4.  Haemophagocytic syndrome and COVID-19.

Authors:  Soledad Retamozo; Pilar Brito-Zerón; Antoni Sisó-Almirall; Alejandra Flores-Chávez; María-José Soto-Cárdenas; Manuel Ramos-Casals
Journal:  Clin Rheumatol       Date:  2021-01-03       Impact factor: 2.980
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.